Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary W Redman

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
JTO Clinical and Research Reports|December 2, 2024
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaAnne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, et al.
Head & Neck|April 11, 2016
Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experienceDaisuke Araki, Mary W Redman, Renato Martins, et al.
The Oncologist|April 10, 2024
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master ProtocolJoel W Neal, Katherine Minichiello, Ryan Brennick, et al.
Current HIV Research|October 28, 2005
CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmissionCarey Farquhar, Dorothy A Mbori-Ngacha, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
AIDS (London, England)|September 9, 2022
A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in UgandaWarren Phipps, Scott V Adams, Peter Mooka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2019
Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)Anne S Tsao, Jieling Miao, Ignacio I Wistuba, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
British Journal of Cancer|August 16, 2017
Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancerZixu Yuan, Kelsey Baker, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)Charu Aggarwal, Mary W Redman, Primo N Lara, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
JTO Clinical and Research Reports|December 2, 2024
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaAnne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, et al.
Head & Neck|April 11, 2016
Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experienceDaisuke Araki, Mary W Redman, Renato Martins, et al.
The Oncologist|April 10, 2024
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master ProtocolJoel W Neal, Katherine Minichiello, Ryan Brennick, et al.
Current HIV Research|October 28, 2005
CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmissionCarey Farquhar, Dorothy A Mbori-Ngacha, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
AIDS (London, England)|September 9, 2022
A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in UgandaWarren Phipps, Scott V Adams, Peter Mooka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2019
Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)Anne S Tsao, Jieling Miao, Ignacio I Wistuba, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
British Journal of Cancer|August 16, 2017
Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancerZixu Yuan, Kelsey Baker, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)Charu Aggarwal, Mary W Redman, Primo N Lara, et al.
Pageof 9